Panacea Biotec Limited (NSE:PANACEABIO)
369.80
+9.15 (2.54%)
Jan 22, 2026, 10:10 AM IST
Panacea Biotec Market Cap
Panacea Biotec has a market cap or net worth of 22.09 billion as of January 21, 2026. Its market cap has decreased by -17.94% in one year.
Market Cap
22.09B
Enterprise Value
21.43B
Revenue
6.04B
Ranking
n/a
PE Ratio
n/a
Stock Price
369.80
Market Cap Chart
Since April 1, 2002, Panacea Biotec's market cap has increased from 21.08B to 22.09B, an increase of 4.81%. That is a compound annual growth rate of 0.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 23.46B | 1.77% |
| Dec 31, 2025 | 23.05B | -10.11% |
| Dec 31, 2024 | 25.64B | 149.32% |
| Dec 29, 2023 | 10.28B | 18.20% |
| Dec 30, 2022 | 8.70B | -28.49% |
| Dec 31, 2021 | 12.17B | -17.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 593.70B |
| Anthem Biosciences | 336.94B |
| OneSource Specialty Pharma | 196.75B |
| Concord Biotech | 131.58B |
| Blue Jet Healthcare | 83.23B |
| Supriya Lifescience | 58.25B |
| Zota Health Care | 39.67B |
| Dishman Carbogen Amcis | 35.86B |